🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cambridge Nutritional Sciences plc (AIM:CNSL)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in GBX
1.391
-0.059 (-4.07%)
Nov 20, 2026, 8:44 AM GMT

AIM:CNSL Income Statement

Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
5.476.988.339.777.558.54
Revenue Growth
-32.11%-16.27%-14.77%29.53%-11.63%25.28%
Cost of Revenue
1.792.252.893.7343.44
Gross Profit
3.684.735.446.053.555.1
Selling, General & Admin
5.265.786.126.676.295.69
Other Operating Expenses
-0.16-0.14-0.28-0.08-0.03-
Operating Expenses
5.45.945.846.586.265.69
Operating Income
-1.72-1.21-0.4-0.54-2.72-0.59
Interest Expense
-0.01-0.01-0.02-0.02-0.01-0.02
Interest & Investment Income
0.040.070.150.05--
EBT Excluding Unusual Items
-1.69-1.15-0.27-0.51-2.73-0.61
Impairment of Goodwill
-3.02-3.02----
Other Unusual Items
-0.11-0.251.83-0.24-0.52-0.34
Pretax Income
-4.82-4.421.57-0.75-3.25-0.95
Income Tax Expense
1.411.41--0.42-0.080.46
Earnings From Continuing Operations
-6.23-5.831.57-0.33-3.17-1.41
Earnings From Discontinued Operations
-----0.69-9.92
Net Income
-6.23-5.831.57-0.33-3.86-11.33
Net Income to Common
-6.23-5.831.57-0.33-3.86-11.33
Net Income Growth
------
Shares Outstanding (Basic)
238238238238231183
Shares Outstanding (Diluted)
238238238238232187
Shares Change
-0.13%-0.13%0.07%2.70%23.98%5.59%
EPS (Basic)
-0.03-0.020.01-0.00-0.02-0.06
EPS (Diluted)
-0.03-0.020.01-0.00-0.02-0.06
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-0.9-1.45-0.280.56-3.18-4.2
Free Cash Flow Per Share
-0.00-0.01-0.000.00-0.01-0.02
Gross Margin
67.26%67.80%65.32%61.86%46.98%59.75%
Operating Margin
-31.47%-17.35%-4.74%-5.47%-35.98%-6.93%
Profit Margin
-113.78%-83.53%18.80%-3.36%-51.15%-132.72%
Free Cash Flow Margin
-16.49%-20.83%-3.38%5.72%-42.10%-49.15%
EBITDA
-1.51-0.99-0.1-0.2-2.39-0.05
EBITDA Margin
-27.62%-14.18%-1.14%-2.05%-31.63%-0.61%
D&A For EBITDA
0.210.220.30.340.330.54
EBIT
-1.72-1.21-0.4-0.54-2.72-0.59
EBIT Margin
-31.47%-17.35%-4.74%-5.47%-35.98%-6.93%